Although membrane-bound HSP70 can be considered as a recognition structure for the innate immune system, tumour cells presenting HSP70 on their cell surface show a higher resistance to radiochemotherapy compared with their membrane HSP70-negative counterparts [40]. The gene discussed is HSPA1A; the disease is neoplasm.